Skip to content
healthcare.dev
Get a free key

Vamousse Lice Treatment

NDC 72238-001, Pediculicide, aerosol, foam, from Alliance Pharma Inc..

Product NDC
72238-001
Status
Listed
Labeler
Alliance Pharma Inc.
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72238-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM CHLORIDE2 [hp_X]/mL

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

Package NDCNDC-11Package
72238-001-01722380001011 BOTTLE, WITH APPLICATOR in 1 BOX (72238-001-01) / 177 mL in 1 BOTTLE, WITH APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 72238-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72238-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72238-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.